Skip to main content
. 2026 Jul 17;26:501. doi: 10.1186/s12890-026-04451-4

Table 2.

Associations between sarcopenia and lung function

Severe airflow limitation PEF PEF% pred
OR (95%CI) P value β (95%CI) P value β (95%CI) P value
Sarcopenia
 Non-sarcopenia 1(Reference) NA 0 (Reference) NA 0 (Reference) NA
 Sarcopenia 1.41 (1.20–1.65) < 0.001 -19.47 (-26.65- -12.29) < 0.001 -0.05 (-0.07- -0.03) < 0.001
 Severe sarcopenia 1.56 (1.26–1.94) < 0.001 -34.02 (-44.27- -23.78) < 0.001 -0.10 (-0.13- -0.07) < 0.001
Sarcopenia item
 Low muscle mass 1.45 (1.25–1.67) < 0.001 -23.13 (-29.84- -16.43) < 0.001 -0.06 (-0.08- -0.05) < 0.001
 Low muscle function 1.65 (1.46–1.86) < 0.001 -27.63 (-32.84- -22.42) < 0.001 -0.07 (-0.09- -0.06) < 0.001
 Low muscle strength 1.75 (1.55–1.99) < 0.001 -36.32 (-42.29- -30.35) < 0.001 -0.10 (-0.11- -0.08) < 0.001

Adjusted for age, sex, body mass index, residence, marital status, education, smoking status, drinking status, chronic lung diseases, asthma and physical activity

Abbreviations: NA not applicable, OR odds ratio, CI confidence interval, PEF peak expiratory flow, PEF% pred percentage of actual PEF in predicted PEF